Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H17N3S |
Molecular Weight | 282.3937 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)Cc1ccccc1Sc2ccc(cc2N)C#N
InChI
InChIKey=UVWLEPXXYOYDGR-BJUDXGSMSA-N
InChI=1S/C16H17N3S/c1-19(2)11-13-5-3-4-6-15(13)20-16-8-7-12(10-17)9-14(16)18/h3-9H,11,18H2,1-2H3/i1-1
Molecular Formula | C16H17N3S |
Molecular Weight | 282.3937 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
3-amino-4-(2[11C]methylaminomethylphenylsulfanyl)benzonitrile (DASB C-11) exhibits excellent in vitro and in vivo properties toward the serotonin transporter. Parametric imaging of serotonin transporters (SERT) with DASB C-11 PET is a useful data analysis tool. DASB C-11 is a suitable PET radioligand for measuring drug occupancy of the SERT in vivo and has potential for monitoring in vivo changes in serotonin levels. Studies in humans showed that the regional distribution of DASB C-11 uptake was concordant with the known densities of SERT sites in the brain. The highest levels of radioactivity were observed in the hypothalamus, intermediate levels were observed in the thalamus and striatum, whereas modest to low levels of radioactivity were observed in the cortical regions and cerebellum, respectively.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. | 2003 Feb |
|
PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. | 2006 Feb |
|
3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies. | 2007 Sep-Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 02:04:32 UTC 2021
by
admin
on
Sat Jun 26 02:04:32 UTC 2021
|
Record UNII |
FJU46Q2BPU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
656408
Created by
admin on Sat Jun 26 02:04:32 UTC 2021 , Edited by admin on Sat Jun 26 02:04:32 UTC 2021
|
PRIMARY | |||
|
FJU46Q2BPU
Created by
admin on Sat Jun 26 02:04:32 UTC 2021 , Edited by admin on Sat Jun 26 02:04:32 UTC 2021
|
PRIMARY | |||
|
296774-13-5
Created by
admin on Sat Jun 26 02:04:32 UTC 2021 , Edited by admin on Sat Jun 26 02:04:32 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
RADIOLIGAND->TARGET | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
VOLUME OF DISTRIBUTION | PHARMACOKINETIC |
|
|
|||